Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 13.

Grischott, Thomas; Falcato, Luis; Senn, Oliver; Puhan, Milo Alan; Bruggmann, Philip (2019). Chronic obstructive pulmonary disease (COPD) among opioid dependent patients in agonist treatment. A diagnostic study. Addiction, 114(5):868-876.

Marzel, Alex; Kusejko, Katharina; Weber, Rainer; Bruggmann, Philip; Rauch, Andri; Roth, Jan A; Bernasconi, Enos; Calmy, Alexandra; Cavassini, Matthias; Hoffmann, Matthias; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Perreau, Matthieu; Günthard, Huldrych F; Kouyos, Roger D; Swiss HIV Cohort Study (2018). The Cumulative Impact of Harm Reduction on the Swiss HIV Epidemic: Cohort Study, Mathematical Model, and Phylogenetic Analysis. Open Forum Infectious Diseases, 5(5):ofy078.

Müllhaupt, Beat; Bruggmann, Philip; Bihl, Florian; Blach, Sarah; Lavanchy, Daniel; Razavi, Homie; Robbins Scott, Sarah; Semela, David; Negro, Francesco (2018). Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030? PLoS ONE, 13(12):e0209374.

Bruggmann, Philip; Blach, Sarah; Deltenre, Pierre; Fehr, Jan; Kouyos, Roger; Lavanchy, Daniel; Müllhaupt, Beat; Rauch, Andri; Razavi, Homie; Schmid, Patrick; Semela, David; Stoeckle, Marcel; Negro, Franco (2017). Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030. Swiss Medical Weekly, 147:w14543.

Bruggmann, Philip. Hepatitis-C-Therapie bei Patienten mit Substanzkonsum in der Schweiz: das Potential der Grundversorgung. 2016, University of Zurich, Faculty of Medicine.

Dickson-Spillmann, Maria; Haug, Severin; Uchtenhagen, Ambros; Bruggmann, Philip; Schaub, Michael P (2016). Rates of HIV and Hepatitis Infections in clients entering heroin-assisted treatment between 2003 and 2013 and risk factors for Hepatitis C infection. European Addiction Research, 22(4):181-191.

Bruggmann, Philip; Negro, Francesco; Bihl, Florian; Blach, Sarah; Lavanchy, Daniel; Müllhaupt, Beat; Razavi, Homie; Semela, David (2015). Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland. Swiss Medical Weekly, 145:w14221.

Müllhaupt, Beat; Bruggmann, Philip; Bihl, Florian; Blach, Sarah; Lavanchy, Daniel; Razavi, Homie; Semela, David; Negro, Francesco (2015). Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland. PLoS ONE, 10(6):e0125214.

Schärer, Verena; Bruggmann, Philip; Müllhaupt, Beat; Fehr, Jan (2014). Behandlung der Hepatitis C - eine Revolution steht bevor. Praxis, 103(19):1123-1131.

Rasi, Manuela; Künzler-Heule, Patrizia; Schmid, Patrick; Semela, David; Bruggmann, Philip; Fehr, Jan; Saxer, Susi; Nicca, Dunja (2014). "Fighting an uphill battle": experience with the HCV triple therapy: a qualitative thematic analysis. BMC Infectious Diseases, 14:507.

Schmidt, Axel J; Falcato, Luis; Zahno, Benedikt; Burri, Andrea; Regenass, Stephan; Müllhaupt, Beat; Bruggmann, Philip (2014). Prevalence of hepatitis C in a Swiss sample of men who have sex with men: whom to screen for HCV infection? BMC Public Health, 14:3.

Gholami, Najibulah; Boesch, Lukas; Falcato, Luis; Stohler, Rudolf; Bruggmann, Philip (2013). QTc prolongation in methadone maintenance - the role of HCV infection. Swiss Medical Weekly, 143:w13852.

Brunner, Nathalie; Senn, Oliver; Rosemann, Thomas; Falcato, Luis; Bruggmann, Philip (2013). Hepatitis C treatment for multimorbid patients with substance use disorder in a primary care-based integrated treatment centre: a retrospective analysis. European Journal of Gastroenterology & Hepatology, 25(11):1300-1307.

This list was generated on Sun Jun 16 04:33:54 2019 CEST.